Quality of Life of Primary Aldosteronism Patients by Mineralocorticoid Receptor Antagonists

CONTEXT: Although primary aldosteronism (PA) reduces quality of life (QOL), there have been no reports on whether treatment with a mineralocorticoid receptor antagonist (MRA) improves QOL in Japanese PA patients. OBJECTIVE: Using the 36-Item Short-Form Health Survey (SF-36), we compared the QOL of P...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Yuichi, Yoshida, Rika, Shibuta, Kanako, Ozeki, Yoshinori, Okamoto, Mitsuhiro, Gotoh, Koro, Masaki, Takayuki, Shibata, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993577/
https://www.ncbi.nlm.nih.gov/pubmed/33817540
http://dx.doi.org/10.1210/jendso/bvab020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993577/
https://www.ncbi.nlm.nih.gov/pubmed/33817540
http://dx.doi.org/10.1210/jendso/bvab020

Ejemplares similares